The comparative efficacy of two commercial tartar control dentifrices in preventing calculus development and facilitating easier dental cleanings

Journal of Clinical Dentistry

Volumn 7, Issue 2, 1996, Pages 58-64

  White, Donald J ^a   McClanahan, Stephen F ^a   Lanzalaco, Anthony C ^a   Cox, Edward R ^a   Bacca, Lori ^a   Perlich, Malcolm A ^a   Campbell, Shelley L ^a   Schiff, Thomas ^a,b,c   Stains, Alice ^b,d  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b Hill Top Research Inc   (United States)

^c UNIVERSITY OF THE PACIFIC   (United States)

^d Clinical Research Unit

Author keywords

[No Author keywords available]

Indexed keywords

FLUORIDE SODIUM; MALEIC ACID DERIVATIVE; POLYVINYL DERIVATIVE; PYROPHOSPHATE; TOOTHPASTE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INSTRUMENTATION; MALE; NONPARAMETRIC TEST; PREVENTIVE DENTISTRY; PRODUCTIVITY; TOOTH BRUSHING; TOOTH CALCULUS;

ADULT; ANALYSIS OF VARIANCE; DENTAL CALCULUS; DENTAL SCALING; DENTIFRICES; DIPHOSPHATES; DOUBLE-BLIND METHOD; EFFICIENCY; FEMALE; HUMANS; MALE; MALEATES; POLYVINYLS; SODIUM FLUORIDE; STATISTICS, NONPARAMETRIC; TOOTHBRUSHING;

EID: 0030325382     PISSN: 08958831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Stookey GK, Jackson RD, Beiswanger BB, Stookey KR: Clinical efficacy of chemicals for calculus prevention. In: ten Cate JM, Ed. Recent Advances in the Study of Dental Calculus, IRL Press, Oxford, pp. 235-258, 1989.
2. Volpe AR, Petrone ME, Davies RM: A review of calculus clinical efficacy studies. J Clin Dent 4:71-81, 1992.
3. White DJ: Processes contributing to the formation of dental calculus. Biofouling 4:209-218, 1991.
4. White DJ: Tartar control dentifrices: Current status and future prospects. In Embery G, Rolla G, Eds. Clinical and Biological Aspects of Dentifrices, Oxford Univ. Press, Oxford, pp. 277-291, 1992.
5. Volpe AR, Manhold JH, Hazen SP: In vivo calculus assessment: Part I: A method and its examiner reproducibility. J Periodontol 36:292-298, 1965.
6. White DJ: Tartar control: Assessment of patient benefits and professional scaling advantages. J Clin Dent 7:27-31, 1996.
7. White DJ, Cox ER, Arends J, Nieborg JH, Leydsman H, Wieringa DW, Dijkman AG, Ruben JR: Instruments and methods for the quantitative measurement of factors affecting therapist/dentist efforts during scaling and , root planing of the teeth. J Clin Dent 7:32-40, 1996.
8. Dijkman AG, Arends J, Ruben JR, White DJ, Cox ER: Crest® tartar control benefits assessed by Quanticalc: Clinical method and three-month results, J Clin Dent 7:41-45, 1996.
9. White DJ, Bollmer BW, Baker RA, Cox ER, Beiswanger BB, Mau M, Tuohy M, Arends J: Quanticalc assessment of the clinical prophylaxis/scaling benefits provided by pyrophosphate dentifrices with and without triclosan, J Clin Dent 7:46-49, 1996.
10. Gaffar A, Esposito A, Afflitto J: In vitro and in vivo anticalculus effects of a triclosan/copolymer system. Am J Dent 3:S37-S42, 1990.
11. Gaffar A, Nabi N, Kashuba B, Williams M, Herles S, Olsen S, Afflitto J: Antiplaque effects of dentifrices containing triclosan/copolymer/NaF system versus triclosan dentifrices without the copolymer. Am J Dent 3:S7-S14, 1990.
12. Gaffar A, Polefka T, Afflitto J, Esposito A, Smith S: In vitro evaluations of pyrophosphate/copolymer/NaF as an anticalculus agent. Comp Cont Educ Dent (Suppl. 8):S242-S250, 1987.
13. Petrone ME, et al: Clinical comparison of the anticalculus efficacy of three commercially available dentifrices. Clin Prev Dent 13:18-21, 1991.
14. Emling RC, et al: A comparison of estimated versus actual brushing time. Pharm Therap Dent 6:93-98, 1981.
15. Wilkins EM: Clinical Practice of the Dental Hygienist, 7th Ed. Lea & Febiger, Baltimore, pp. 472-522, 1994.
16. McCaughey C: Binding of polyphosphates and phosphonates to hydroxy-apatite, subsequent hydrolysis, phosphate exchange and effects on demineralization, mineralization and microcrystal aggregation. Caries Res 17:229-241, 1983.